CTO Crossing catheters

Peripheral Vascular Market Expected to See Strong Market Growth

According to Millennium Research Group (MRG), increasing awareness and diagnosis of peripheral vascular disease (PVD) along with the introduction of improved next-generation devices will lead the United States peripheral vascular (PV) device marke...

Avinger Ocelot OCT CTO catheter
FDA Clears First Forward-Looking Imaging Catheter to Treat Chronic Total Occlusions

The U.S. Food and Drug Administration (FDA) has granted market clearance for the Avinger Inc. Ocelot optical coherenace tomography (OCT) catheter to help cross chronic total occlusions (CTOs) in patients with per...

Boston Scientific to Acquire CTO Catheter Company BridgePoint Medical

September 20, 2012 — Boston Scientific Corp. has signed a definitive agreement to acquire BridgePoint Medical Inc., a privately held company based in Minneapolis. BridgePoint Medical has developed a proprietary, catheter-based system to treat coro...

Covidien Adds CTO Crossing and Re-Entry Catheters for Peripheral Artery Disease
Covidien Adds CTO Crossing and Re-Entry Catheters for Peripheral Artery Disease

Covidien announced the launch of the Viance Crossing Catheter and Enteer Re-entry System for treating chronic total occlusions (CTOs) endovascularly. The devices are now available in the United States, the European Union (EU) and other select inte...

guidewire, CTO
FDA Approves Use of Common Abbott Devices to Treat for...
Physicians have new tools for treating chronic total occlusions (CTOs) after Abbott received U.S. Food and Drug Administration (FDA) approval for guidewires...
Millennium Research Group Peripheral Vascular Device Market Growth
Peripheral Vascular Market Expected to See Strong Market...
According to Millennium Research Group (MRG), increasing awareness and diagnosis of peripheral vascular disease (PVD) along with the introduction of improved...
Avinger Ocelot OCT CTO catheter
FDA Clears First Forward-Looking Imaging Catheter to Treat...
The U.S. Food and Drug Administration (FDA) has granted market clearance for the Avinger Inc. Ocelot optical coherenace tomography (OCT)...
CONNECT II Clinical Trial CTO Crossing Catherter Peripheral Artery Disease
Study Show Success With Forward-Looking CTO Crossing...
Avinger Inc., a medical device manufacturer of multi-functional catheters for crossing CTOs in patients with peripheral artery disease (PAD), announced its...
Avinger Ocelot OCT CTO catheter
  The Avinger Ocelot optical coherenace tomography (OCT) catheter helps cross chronic total occlusions (CTOs) in
Viance Crossing Catheter and Enteer Re-entry System Offer New Approach to Chronic Total Occlusions
The Viance Crossing Catheter and Enteer Re-entry System treat chronic total occlusions (CTOs) endovascularly. The devices are available in...
Boston Scientific TruePath Aid Crossing CTOs
The Boston Scientific TruePath CTO device, designed to facilitate the crossing of chronic total occlusions (CTOs) within the peripheral...
Avinger Wildcat Catheter Sees First Michigan Use
The U.S. Food and Drug Administration (FDA)-cleared catheterization tool, known as the Avinger Wildcat Catheter, uses the automated tip...
View All »

Articles

guidewire, CTO
FDA Approves Use of Common Abbott Devices to Treat for...
Physicians have new tools for treating chronic total occlusions (CTOs) after Abbott received U.S. Food and Drug Administration (FDA) approval for guidewires...
Millennium Research Group Peripheral Vascular Device Market Growth
Peripheral Vascular Market Expected to See Strong Market...
According to Millennium Research Group (MRG), increasing awareness and diagnosis of peripheral vascular disease (PVD) along with the introduction of improved...
Avinger Ocelot OCT CTO catheter
FDA Clears First Forward-Looking Imaging Catheter to Treat...
The U.S. Food and Drug Administration (FDA) has granted market clearance for the Avinger Inc. Ocelot optical coherenace tomography (OCT)...
When to Consider Revascularization of Coronary Chronic...
Management of coronary chronic total occlusion (CTO) is individualized depending on the severity of symptoms, ischemia and on the severity of concomitant...

Video Center

view all Videos »

The Radial Access Adoption Report Card
Over the past decade in the United States, there has been growing interest in transradial artery...
10 weeks 5 days ago
Game-Changing Technologies to Watch in 2013
My job as editor of DAIC is to help readers keep tabs on the latest in cardiovascular technology...
15 weeks 10 hours ago
Innovation Exasperation
In a recent LinkedIn Medical Device Group posting, it was noted that DuVal & Associates, P.A....
18 weeks 5 days ago
View All »
EP lab, Tom De potter, depotter, angiography dose reduction
Less is More — Radiation Exposure Reduction in the EP Lab
This webinar focuses on implementation of different strategies to reduce radiation exposure during interventional electrophysiology (EP) procedures. It offers an overview of the current state-of-the-...
Iterative Reconstruction in CT: Understanding and Implementation
Radiation exposure from multidetector CT (MDCT) has become a pressing public health concern in both lay and medical publications. Implementation of iterative reconstruction offers radiologists the...
Healthcare Reform: What’s the Immediate Impact on Cardiovascular IT?
The recent U.S. Supreme Court ruling upholding the 2010 Affordable Care Act (ACA) may have significant impact on healthcare providers and their cardiovascular departments. While the ruling will...

Comparison Charts

Sorry there is no data available